Bone marrow findings in HIV-positive patients with kaposi sarcoma herpesvirus-associated multicentric castleman disease

American Journal of Clinical Pathology

Volumn 139, Issue 5, 2013, Pages 651-661

  Venkataraman, Girish ^a   Uldrick, Thomas S ^a   Aleman, Karen ^a   O'Mahony, Deirdre ^a   Karcher, Donald S ^b   Steinberg, Seth M ^a   Raffeld, Mark A ^a   Marshall, Vickie ^c   Whitby, Denise ^c   Little, Richard F ^a   Yarchoan, Robert ^a   Pittaluga, Stefania ^a   Maric, Irina ^d  

^a NATIONAL CANCER INSTITUTE   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c SAIC FREDERICK INC   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Bone marrow; Bone marrow examination; Human herpesvirus 8; Human immunodeficiency virus; Kaposi sarcoma herpesvirus; Multicentric Castleman disease; Plasmacytosis

Indexed keywords

CYTOTOXIC AGENT; INTERLEUKIN 6; LATENCY ASSOCIATED NUCLEAR ANTIGEN; RITUXIMAB; VALGANCICLOVIR; ZIDOVUDINE;

ADULT; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; BONE MARROW BIOPSY; CLINICAL ARTICLE; CLINICAL FEATURE; CYTOPENIA; FEMALE; HERPES VIRUS INFECTION; HISTOPATHOLOGY; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LIGHT CHAIN; LYMPHOID CELL; MALE; MONONUCLEAR CELL; MULTIPLE CANCER; PLASMA CELL; PLASMACYTOSIS; PRIORITY JOURNAL; VIRUS LOAD;

ADULT; BONE MARROW CELLS; BONE MARROW NEOPLASMS; DNA, VIRAL; FEMALE; GIANT LYMPH NODE HYPERPLASIA; HERPESVIRUS 8, HUMAN; HIV SEROPOSITIVITY; HUMANS; LYMPH NODES; MALE; MIDDLE AGED; SARCOMA, KAPOSI; SPLEEN; VIRAL LOAD;

EID: 84878085849     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPKGF7U8AWQBVG     Document Type: Article

References (34)

1. Soulier J, Grollet L, Oksenhendler E, et al. Kaposi's sarcoma-Associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood. 1995;86:1276-1280.
2. Oksenhendler E, Duarte M, Soulier J, et al. Multicentric Castleman's disease in HIV infection: a clinical and pathological study of 20 patients. AIDS. 1996;10:61-67.
3. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-Associated Kaposi's sarcoma. Science. 1994;266:1865-1869.
4. Whitby D, Howard MR, Tenant-Flowers M, et al. Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet. 1995;346:799-802.
5. Moore PS, Kingsley LA, Holmberg SD, et al. Kaposi's sarcoma-Associated herpesvirus infection prior to onset of Kaposi's sarcoma. AIDS. 1996;10:175-180.
6. Cesarman E, Chang Y, Moore PS, et al. Kaposi's sarcoma-Associated herpesvirus-like DNA sequences in AIDSrelated body-cavity-based lymphomas. N Engl J Med. 1995;332:1186-1191.
7. Oksenhendler E, Carcelain G, Aoki Y, et al. High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric Castleman disease in HIV-infected patients. Blood. 2000;96:2069-2073.
8. Aoki Y, Jaffe ES, Chang Y, et al. Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-Associated herpesvirus-encoded interleukin-6. Blood. 1999;93:4034-4043.
9. Bower M, Veraitch O, Szydlo R, et al. Cytokine changes during rituximab therapy in HIV-Associated multicentric Castleman disease. Blood. 2009;113:4521-4524.
10. Aoki Y, Tosato G, Fonville TW, et al. Serum viral interleukin-6 in AIDS-related multicentric Castleman disease. Blood. 2001;97:2526-2527.
11. Osborne J, Moore PS, Chang Y. KSHV-encoded viral IL-6 activates multiple human IL-6 signaling pathways. Hum Immunol. 1999;60:921-927.
12. Uldrick TS, Wang V, O'Mahony D, et al. An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-Associated herpesvirus and HIV but without multicentric Castleman disease. Clin Infect Dis. 2010;51:350-358.
13. Oksenhendler E, Boulanger E, Galicier L, et al. High incidence of Kaposi sarcoma-Associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. Blood. 2002;99:2331-2336.
14. Collins LS, Fowler A, Tong CY, et al. Multicentric Castleman's disease in HIV infection. Int J STD AIDS. 2006;17:19-24; quiz 25.
15. Uldrick TS, Polizzotto MN, Aleman K, et al. Highdose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-Associated multicentric Castleman disease: a pilot study of virus-Activated cytotoxic therapy. Blood. 2011;117:6977-6986.
16. Bower M, Powles T, Williams S, et al. Brief communication: rituximab in HIV-Associated multicentric Castleman disease. Ann Intern Med. 2007;147:836-839.
17. Gerard L, Berezne A, Galicier L, et al. Prospective study of rituximab in chemotherapy-dependent human immunodeficiency virus-Associated multicentric Castleman's disease: ANRS 117 CastlemaB Trial. J Clin Oncol. 2007;25:3350-3356.
18. Engels EA, Pfeiffer RM, Goedert JJ, et al. Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS. 2006;20:1645-1654.
19. Powles T, Stebbing J, Bazeos A, et al. The role of immune suppression and HHV-8 in the increasing incidence of HIV-Associated multicentric Castleman's disease. Ann Oncol. 2009;20:775-779.
20. Bacon CM, Miller RF, Noursadeghi M, et al. Pathology of bone marrow in human herpes virus-8 (HHV8)-Associated multicentric Castleman disease. Br J Haematol. 2004;127:585-591.
21. Kreft A, Weber A, Springer E, et al. Bone marrow findings in multicentric Castleman disease in HIV-negative patients. Am J Surg Pathol. 2007;31:398-402.
22. Dao LN, Hanson CA, Dispenzieri A, et al. Bone marrow histopathology in POEMS syndrome: a distinctive combination of plasma cell, lymphoid, and myeloid findings in 87 patients. Blood. 2011;117:6438-6444.
23. Malope BI, Pfeiffer RM, Mbisa G, et al. Transmission of Kaposi sarcoma-Associated herpesvirus between mothers and children in a South African population. J Acquir Immune Defic Syndr. 2007;44:351-355.
24. de Sanjose S, Marshall V, Sola J, et al. Prevalence of Kaposi's sarcoma-Associated herpesvirus infection in sex workers and women from the general population in Spain. Int J Cancer. 2002;98:155-158.
25. Yuan CC, Miley W, Waters D. A quantification of human cells using an ERV-3 real time PCR assay. J Virol Methods. 2001;91:109-117.
26. Karcher DS, Frost AR. The bone marrow in human immunodeficiency virus (HIV)-related disease: morphology and clinical correlation. Am J Clin Pathol. 1991;95:63-71.
27. Meggetto F, Cesarman E, Mourey L, et al. Detection and characterization of human herpesvirus-8-infected cells in bone marrow biopsies of human immunodeficiency viruspositive patients. Hum Pathol. 2001;32:288-291.
28. Brandt SJ, Bodine DM, Dunbar CE, et al. Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice. J Clin Invest. 1990;86:592-599.
29. Rousset F, Garcia E, Defrance T, et al. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci U S A. 1992;89:1890-1893.
30. Burdin N, Rousset F, Banchereau J. B-cell-derived IL-10: production and function. Methods. 1997;11:98-111.
31. Jones KD, Aoki Y, Chang Y, et al. Involvement of interleukin-10 (IL-10) and viral IL-6 in the spontaneous growth of Kaposi's sarcoma herpesvirus-Associated infected primary effusion lymphoma cells. Blood. 1999;94:2871-2879.
32. Bailey DP, Kashyap M, Bouton LA, et al. Interleukin-10 induces apoptosis in developing mast cells and macrophages. J Leukoc Biol. 2006;80:581-589.
33. Mirmonsef P, Shelburne CP, Fitzhugh Yeatman C II, et al. Inhibition of Kit expression by IL-4 and IL-10 in murine mast cells: role of STAT6 and phosphatidylinositol 3'-kinase. J Immunol. 1999;163:2530-2539.
34. Schreiber S, Fedorak RN, Nielsen OH, et al, for the Crohn's Disease IL-10 Cooperative Study Group. Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Gastroenterology. 2000;119:1461-1472.